Aprea Therapeutics, Inc. (APRE) SEC filings
APRE SEC filings moved a median of -1.99% by the close. APRE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the APRE overview →
77 measured APRE SEC filing events.
Where these APRE SEC filings landedvs 75 measured APRE SEC filing reactions
| Middle 50% of APRE SEC filing reactions | -4.55% to -0.09% |
|---|---|
| Median reaction (to close) | -1.99% |
| Measured reactions | 75 |
Point-in-time · zero look-ahead
Half of the 75 APRE SEC filing events with a measured close landed between -4.55% and -0.09%; 24% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Aprea Therapeutics, Inc. For: Aug 28 | SEC filing · Form 8-K | -1.69% | -4.71% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -10.37% | -12.44% | |
| Form 8-K Aprea Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | -10.37% | -12.44% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jul 23 | SEC filing · Form 8-K | +7.37% | -2.92% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jun 16 | SEC filing · Form 8-K | -0.89% | -9.49% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | -9.13% | |
| Form 8-K Aprea Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | — | -9.13% | |
| Form ARS Aprea Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | -0.63% | -1.19% | |
| Form DEF 14A Aprea Therapeutics, Inc. For: Jun 16 | SEC filing · Form DEF | -0.63% | -1.19% | |
| Form DEFA14A Aprea Therapeutics, Inc. | SEC filing · Form DEFA14A | -0.63% | -1.19% | |
| Form EFFECT Aprea Therapeutics, Inc. | SEC filing · Form EFFECT | -0.63% | -1.19% | |
| Form S-3 Aprea Therapeutics, Inc. | SEC filing · Form S-3 | +0.17% | -6.92% | |
| Form PRE 14A Aprea Therapeutics, Inc. For: Jun 16 | SEC filing · Form PRE | -1.96% | -3.82% | |
| Form 8-K Aprea Therapeutics, Inc. For: Apr 01 | SEC filing · Form 8-K | -1.48% | -5.02% | |
| Form 8-K Aprea Therapeutics, Inc. For: Mar 30 | SEC filing · Form 8-K | -0.63% | +9.87% | |
| Form EFFECT Aprea Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | -0.17% | |
| Form S-3/A Aprea Therapeutics, Inc. | SEC filing · Form S-3 | — | -6.27% | |
| Form 10-K Aprea Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -7.91% | -9.99% | |
| Form 8-K Aprea Therapeutics, Inc. For: Mar 16 | SEC filing · Form 8-K | -7.91% | -9.99% | |
| Form S-8 Aprea Therapeutics, Inc. | SEC filing · Form S-8 | -2.22% | +2.92% | |
| Form S-3 Aprea Therapeutics, Inc. | SEC filing · Form S-3 | -4.04% | -6.41% | |
| Form 8-K Aprea Therapeutics, Inc. For: Feb 18 | SEC filing · Form 8-K | -0.65% | +3.19% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jan 28 | SEC filing · Form 8-K | +4.31% | +30.49% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jan 23 | SEC filing · Form 8-K | +0.00% | -2.73% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jan 09 | SEC filing · Form 8-K | +1.48% | -1.07% | |
| Form EFFECT Aprea Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | -3.26% | |
| Form D Aprea Therapeutics, Inc. | SEC filing · Form D | -2.95% | -8.87% | |
| Form S-3 Aprea Therapeutics, Inc. | SEC filing · Form S-3 | +3.28% | -1.01% | |
| Form 8-K Aprea Therapeutics, Inc. For: Dec 08 | SEC filing · Form 8-K | -4.11% | -8.78% | |
| Form S-8 Aprea Therapeutics, Inc. | SEC filing · Form S-8 | +0.00% | -1.89% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.56% | |
| Form 8-K Aprea Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | +0.00% | -1.56% | |
| Form 8-K Aprea Therapeutics, Inc. For: Oct 24 | SEC filing · Form 8-K | -1.13% | -3.45% | |
| Form 8-K Aprea Therapeutics, Inc. For: Oct 15 | SEC filing · Form 8-K | +0.00% | -1.32% | |
| Form 8-K Aprea Therapeutics, Inc. For: Sep 08 | SEC filing · Form 8-K | +0.14% | +3.87% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Aprea Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K Aprea Therapeutics, Inc. For: Jun 05 | SEC filing · Form 8-K | +0.00% | +5.08% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +10.00% | +2.00% | |
| Form 8-K Aprea Therapeutics, Inc. For: May 14 | SEC filing · Form 8-K | +10.00% | +2.00% | |
| Form ARS Aprea Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | — | -4.46% | |
| Form DEF 14A Aprea Therapeutics, Inc. For: Jun 05 | SEC filing · Form DEF | — | -4.46% | |
| Form DEFA14A Aprea Therapeutics, Inc. | SEC filing · Form DEFA14A | — | -4.46% | |
| Form 10-K Aprea Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.21% | -3.10% | |
| Form 8-K Aprea Therapeutics, Inc. For: Mar 25 | SEC filing · Form 8-K | +2.21% | -3.10% | |
| Form 8-K Aprea Therapeutics, Inc. For: Feb 05 | SEC filing · Form 8-K | +5.36% | -3.63% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jan 13 | SEC filing · Form 8-K | -3.52% | -3.66% | |
| Form 8-K Aprea Therapeutics, Inc. For: Nov 08 | SEC filing · Form 8-K | +0.00% | -6.63% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.79% | |
| Form 8-K Aprea Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | +0.00% | +1.79% | |
| Form 8-K Aprea Therapeutics, Inc. For: Oct 23 | SEC filing · Form 8-K | -5.25% | -6.70% | |
| Form 8-K Aprea Therapeutics, Inc. For: Oct 09 | SEC filing · Form 8-K | — | -1.92% | |
| Form S-8 Aprea Therapeutics, Inc. | SEC filing · Form S-8 | — | +0.00% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -4.17% | |
| Form 8-K Aprea Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | +0.00% | -4.17% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jun 20 | SEC filing · Form 8-K | +5.97% | -0.25% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jun 17 | SEC filing · Form 8-K | +0.00% | -2.33% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.90% | +6.32% | |
| Form 8-K Aprea Therapeutics, Inc. For: May 14 | SEC filing · Form 8-K | +0.90% | +6.32% | |
| Form EFFECT Aprea Therapeutics, Inc. | SEC filing · Form EFFECT | — | -0.58% | |
| Form ARS Aprea Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | +6.57% | |
| Form DEF 14A Aprea Therapeutics, Inc. For: Jun 20 | SEC filing · Form DEF | +0.00% | +6.57% | |
| Form DEFA14A Aprea Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | +6.57% | |
| Form 8-K Aprea Therapeutics, Inc. For: Apr 10 | SEC filing · Form 8-K | +0.50% | -1.99% | |
| Form S-3 Aprea Therapeutics, Inc. | SEC filing · Form S-3 | — | -4.64% | |
| Form 10-K Aprea Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.99% | |
| Form 8-K Aprea Therapeutics, Inc. For: Mar 26 | SEC filing · Form 8-K | +0.00% | -1.99% | |
| Form 8-K Aprea Therapeutics, Inc. For: Mar 11 | SEC filing · Form 8-K | +0.16% | -10.19% | |
| Form 8-K Aprea Therapeutics, Inc. For: Feb 06 | SEC filing · Form 8-K | -4.91% | -14.14% | |
| Form EFFECT Aprea Therapeutics, Inc. | SEC filing · Form EFFECT | -7.81% | +11.38% | |
| Form 8-K Aprea Therapeutics, Inc. For: Feb 02 | SEC filing · Form 8-K | -7.81% | +11.38% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jan 26 | SEC filing · Form 8-K | +0.00% | -1.89% | |
| Form S-3 Aprea Therapeutics, Inc. | SEC filing · Form S-3 | +0.00% | -1.89% | |
| Form 8-K Aprea Therapeutics, Inc. For: Jan 04 | SEC filing · Form 8-K | — | +0.60% | |
| Form 10-Q Aprea Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -4.00% | |
| Form 8-K Aprea Therapeutics, Inc. For: Nov 09 | SEC filing · Form 8-K | — | -4.00% | |
| Form S-8 Aprea Therapeutics, Inc. | SEC filing · Form S-8 | — | -4.00% |
Keep exploring
More APRE: earnings → · analyst actions → · APRE overview →
Other Industrials names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Embraer S.A. (ERJ) | 222 | +0.13% | 59% |
| Triumph Group, Inc. (TGI) | 222 | 0.00% | 48% |
| LEGACY ACQUISTION CORP (LGC) | 221 | 0.00% | 16% |
| TOMI Environmental Solutions, Inc. (TOMZ) | 220 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.